Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

enthalten in: Clinical infectious diseases | 2017

von Navalkele, B. | Pogue, J. | Karino, S. | +16

Editorial Commentary : Colistin Dosing: Does the Fun Ever Start?

enthalten in: Clinical infectious diseases | 2016

von Pogue, J. | Ortwine, J. | Kaye, K.

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin/tazobactam Compared to those on Vancomycin and Cefepime

enthalten in: Clinical infectious diseases | 2016

von Navalkele, B. | Pogue, J. | Karino, S. | +16

Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed

enthalten in: Clinical infectious diseases | 2015

von Pogue, J. | Cohen, D. | Marchaim, D.

Optimal Usage of Colistin: Are We Any Closer?

enthalten in: Clinical infectious diseases | 2015

von Pogue, J. | Ortwine, J. | Kaye, K.